enGene Holdings Inc. Quarterly Operating Income (Loss) in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
enGene Holdings Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2022 to Q3 2024.
  • enGene Holdings Inc. Operating Income (Loss) for the quarter ending October 31, 2024 was -$17.5M, a 67.2% decline year-over-year.
  • enGene Holdings Inc. Operating Income (Loss) for the twelve months ending October 31, 2024 was -$62.3M, a 139% decline year-over-year.
  • enGene Holdings Inc. annual Operating Income (Loss) for 2024 was -$62.3M, a 139% decline from 2023.
  • enGene Holdings Inc. annual Operating Income (Loss) for 2023 was -$26.1M, a 34.1% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$62.3M -$17.5M -$7.01M -67.2% Aug 1, 2024 Oct 31, 2024 10-K 2024-12-19
Q2 2024 -$55.3M -$16.8M -$10.5M -168% May 1, 2024 Jul 31, 2024 10-Q 2024-09-10
Q1 2024 -$44.8M -$17.3M -$12.6M -265% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 -$32.2M -$10.8M -$6.14M -133% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 -$26.1M -$10.4M Aug 1, 2023 Oct 31, 2023 10-K 2024-12-19
Q2 2023 -$6.25M May 1, 2023 Jul 31, 2023 10-Q 2024-09-10
Q1 2023 -$4.74M Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 -$4.63M Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.